GPI 定障碍和心脏:心肌病是一种被忽视的特征吗?
Allan Bayat1,2,3, Tobias Lindau4, Angel Aledo-Serrano5
1Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.
Clinical genetics
|July 25, 2023
概括
葡萄糖酸氨基醇定障碍 (GPI-ADs) 可能导致心肌病,一种严重的心脏病. 早期心脏查对于患有GPI-AD的患者来说至关重要,以检测这种可能致命的并发症.
科学领域:
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
- 罕见疾病 罕见疾病
背景情况:
- 甘氨基酸酸氨基醇定障碍 (GPI-ADs) 是一种罕见的遗传疾病,会影响糖化.
- 超过30个基因参与GPI生物合成,其中24个与神经发育问题有关.
- PIGA脑病变,GPI-AD,与高死亡率有关,有时是由于心肌病变.
研究的目的:
- 调查GPI-ADs患者心肌病的发生率.
- 提高对心肌病的认识,作为GPI-ADs.的关键表现.
- 强调需要对受影响个体进行心脏监测.
主要方法:
- 国际合作,以识别和招募新的患者与GPI-ADs和心肌病.
- 关于GPI-AD相关心肌病的已发表病例的综合文献综述.
- 联系作者以获取其他患者数据和临床信息.
主要成果:
- 确定了四名新的,与GPI-AD和心肌病症无关的患者.
- 所有患者在成年之前都被诊断出心肌病,导致两例的早期死亡.
- 所有确诊的患者都患有PIGA脑病变;三个患者在相同的残留物中共享引起疾病的变异.
- 文献搜索揭示了GPI-AD相关心肌病的五个额外的儿科病例,其中三例在成年之前死亡.
结论:
- 患有GPI-ADs的患者面临患心肌病的显著风险.
- 定期进行心脏查,包括心声回声,对于早期检测和管理至关重要.
- 这突出了心肌病作为一种潜在的致命特征,需要在GPI-AD患者中保持临床警.
关键词:
在GPI中,GPI是指标.这是一个GPIAD.皮加 (Piga) 是一个名字.心肌病性心脏病 - 心肌病性心脏病遗传学 遗传学 遗传学 是一个草甘酸氨基醇生物合成缺陷心灵的心灵心灵的心灵心灵的心灵死亡率 死亡率更多相关视频
相关概念视频
01:29GPI Anchoring of Proteins in the ER Membrane
4.1K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
4.1K
01:25Cardiomyopathy I: Introduction and Classification
16
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
16
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17